[1] World Health Organization.Global tuberculosis control[S] . WHO, 2012.
[2] Srensen AL, Nagai S, Hoven G, et al. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis[J] .Infect Immun, 1995, 63(5): 1710-1717.
[3] Bergstedt W, Tingskov PN, Thierry-Carstensen B, et al. First-in-man open clinical trial of a combined rdESAT-6 and rCFP-10 tuberculosis specific skin test reagent[J] . PLoS One, 2010, 5(6) :e11277.
[4] Arend SM, Franken WP, Aggerbeck H, et al. Double-blind randomized Phase I study comparing rdESAT-6 to tuberculin as skin test reagent in the diagnosis of tuberculosis infection[J] . Tuberculosis, 2008, 88(3): 249-261.
[5] Aggerbeck H, Madsen SM. Safety of ESAT-6[J] . Tuberculosis (Edinb), 2005, 86(5):363-373.
[6] Luo F, Sun X, Wang Y, et al. Ficolin-2 defends against virulent Mycobacteria tuberculosis infection in vivo, and its insufficiency is associated with infection in humans[J] . PLoS One, 2013, 8(9): e73859.
[7] Xu Z, Lu D, Zhang X, et al. Mycobacterium smegmatis in skin biopsy specimens from patients with suppurative granulomatous inflammation[J] . J Clin Microbiol, 2013, 51(3):1028-1030.
[8] Mishra S, Bhagavat R, Chandra N, et al. Cloning, expression, purification, and biochemical characterisation of the FIC motif containing protein of Mycobacterium tuberculosis[J] . Protein Expr Purif, 2012, 86(1):58-67.
[9] Fan XY, Ma H, Guo J, et al. A novel differential expression system for gene modulation in Mycobacteria[J] . Plasmid, 2009, 61(1):39-46.
[10] 郭 建,范齐文,卢水华,等.肺外结核感染的快速分子检测和菌株分型方法的应用[J] .中华检验医学杂志, 2013, 36(7):620-624.
[11] 岳乔红,苏明权,杨军兰,等. 以结核分枝杆菌38 kD 重组蛋白为抗原的血清学诊断[J] . 中国生物制品学杂志, 2006, 19(6): 633-635.
[12] 吴雪琼,张俊仙,哈光平,等. 结核分枝杆菌katG 蛋白的表达和纯化及血清学诊断价值[J] . 中华检验医学杂志, 2003, 26(5): 310-311.
[13] 郭 建,范小勇,马 辉,等. 结核分枝杆菌ESAT-6重组二聚体的表达、纯化及其在血清学诊断中的初步应用[J] . 中国生物制品学杂志, 2009, 22(2):128-131.
[14] Harboe M, Oettinger T, Wiker HG, et al. Evidence for occurrence of ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG[J] . Infect Immun, 1996, 64(1): 16-22.
[15] Sebina I, Cliff JM, Smith SG, et al. Long-lived memory B-cell responses following BCG vaccination[J] . PLoS One, 2012, 7(12):e51381.
[16] Tsolaki AG, Nagy J, Leiva S, et al. Mycobacterium tuberculosis antigen 85B and ESAT-6 expressed as a recombinant fusion protein in Mycobacterium smegmatis elicits cell-mediated immune response in a murine vaccination model[J] . Mol Immunol, 2013, 54(3-4): 278-83.
[17] Fan X, Gao Q, Fu R. DNA vaccine encoding ESAT-6 enhances the protective efficacy of BCG against Mycobacterium tuberculosis infection in mice[J] . Scand J Immunol, 2007, 66(5): 523-528.
[18] Brandt L, Elhay M, Rosenkrands I, et al. ESAT-6 subunit vaccination against Mycobacterium tuberculosis[J] . Infect Immun, 2000, 68(2): 791-795.
[19] Li Z, Song D, Zhang H, et al. Improved humoral immunity against tuberculosis ESAT-6 antigen by chimeric DNA prime and protein boost strategy[J] . DNA Cell Biol, 2006, 25(1): 25-30. |